Painful nipple hyperkeratosis secondary to vemurafenib
Sign Up to like & getrecommendations! Published in 2017 at "Dermatologic Therapy"
DOI: 10.1111/dth.12477
Abstract: Vemurafenib is a selected BRAF kinase inhibitor approved for treating metastatic or unresectable melanoma, which has numerous cutaneous side effects unfortunately, including three previously reported cases of asymptomatic areola and/or nipple hyperkeratosis. We present the… read more here.
Keywords: hyperkeratosis secondary; nipple hyperkeratosis; painful nipple; vemurafenib ... See more keywords